January 2020 in “Journal of The European Academy of Dermatology and Venereology” In 2019, dermatology and venereology improved skin cancer imaging, advanced in treating skin conditions like psoriasis, and explored the skin microbiome's role in diseases.
10 citations,
October 2020 in “Journal of The American Academy of Dermatology” Taking spironolactone doesn't increase the chance of breast cancer coming back.
132 citations,
November 1998 in “Journal of the American Academy of Dermatology” Topical sensitizers have mixed success in treating alopecia areata.
August 2024 in “Archives of Dermatological Research” Low-dose oral minoxidil is effective and safe for treating androgenetic alopecia.
5 citations,
May 2018 in “European journal of pharmacology” Fesoterodine is effective and safe for elderly patients with overactive bladder.
1 citations,
January 2024 in “Journal of Cutaneous and Aesthetic Surgery” Fractional CO2 laser with topical triamcinolone is more effective and safer for treating alopecia areata than intralesional triamcinolone.
53 citations,
August 2014 in “Cochrane library” Methotrexate is not proven effective for inducing remission in ulcerative colitis.
November 2023 in “Bioengineering” AMT® is effective and safe for early-stage knee osteoarthritis.
8 citations,
January 2019 in “Clinical research and trials” The study evaluated the long-term efficacy and safety of 1 mg/day finasteride in 532 Japanese men with androgenetic alopecia over 10 years. Results showed that 91.5% of patients experienced improvement, and 99.1% prevented disease progression. The Norwood-Hamilton classification improved by approximately 1 grade, and the modified global photographic assessment score showed significant improvement. Subjective evaluations indicated high satisfaction and perceived improvement. No serious adverse reactions were reported, with only mild and temporary side effects in 6.8% of participants. The study concluded that long-term finasteride treatment was effective and safe for Japanese men with androgenetic alopecia, with better efficacy in early-stage patients.
2 citations,
October 2020 in “The Journal of clinical and aesthetic dermatology” The herbal mix (Biochanin A, Acetyl tetrapeptide-3, and Ginseng Extracts) and the 3% Minoxidil solution are equally effective in treating hair loss, but the herbal mix has fewer side effects.
2 citations,
July 2023 in “Journal of cosmetic dermatology” JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.
This pilot, open randomized trial compared the efficacy and safety of topical minoxidil 2% alone versus a combination of topical minoxidil 2% and platelet-rich plasma (PRP) in 26 women with female pattern hair loss (FPHL). Both groups showed significant increases in hair density (34.92 ± 8.39 hairs/cm² for the combination group and 31.21 ± 8.30 hairs/cm² for the minoxidil-only group) and significant reductions in hair pull test results. Patient satisfaction scores were similar, with 16.7% in the combination group and 28.6% in the minoxidil-only group reporting high satisfaction. No major side effects were observed. The study concluded that while the combination therapy is effective, it is not superior to minoxidil alone, though PRP may be beneficial for patients with compliance issues related to minoxidil.
June 2022 in “International Journal of Research in Dermatology” Injectable platelet-rich fibrin is a safe and effective treatment for hair loss.
2 citations,
February 2021 in “Case reports in dermatological medicine” The new topical botanical formulation significantly regrew hair in all five patients without side effects.
August 2023 in “Skin Research and Technology” Platelet-rich plasma (PRP) may improve healing in chronic wounds and vitiligo and promote hair regrowth, but more research is needed.
January 2023 in “International Journal of Trichology” PRP therapy for hair loss is safe but its effectiveness is doubtful.
8 citations,
June 2022 in “Frontiers in Medicine” Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.
April 2024 in “Military Medical Research/Military medical research” Cellular and immunotherapies show promise for healing chronic wounds but need more research.
January 2024 in “Journal der Deutschen Dermatologischen Gesellschaft” Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.
March 2023 in “Anais Brasileiros De Dermatologia” The document reviews various treatments for female pattern hair loss (FPHL), highlighting the efficacy and safety of different therapeutic options. Topical minoxidil is the most supported treatment but is ineffective for about 40% of patients. Oral minoxidil shows promise but has potential side effects. Antiandrogens like spironolactone and bicalutamide are effective in certain cases, with cyproterone being more effective in hyperandrogenism. Emerging treatments like microneedling, platelet-rich plasma (PRP) therapy, and low-level laser therapy (LLLT) show potential but require more research. The review emphasizes the need for personalized treatment plans and further randomized clinical trials to improve FPHL management.
December 2022 in “Archives of Dermatological Research” This randomized, double-blind, placebo-controlled study compared the efficacy and safety of topical cetirizine with minoxidil versus topical placebo with minoxidil in 66 female patients with androgenetic alopecia over 24 weeks. The cetirizine group showed significant improvements in hair density, hair shaft thickness, and the average number of hairs per follicular unit, particularly in the vertex area, compared to the placebo group. Patients in the cetirizine group also reported better self-assessment scores. Side effects were similar between the two groups, indicating that cetirizine is a safe and effective addition to minoxidil for treating female androgenetic alopecia.
78 citations,
October 2003 in “Cochrane library” Cyproterone acetate with estradiol may subjectively improve excessive hair growth in women, but it's not clinically better than other treatments.
36 citations,
September 2017 in “Journal of controlled release” A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.
25 citations,
October 2018 in “Pediatric dermatology” Ustekinumab helped three kids with alopecia areata regrow hair.
21 citations,
May 2017 in “Paediatric drugs” Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.
2 citations,
February 2021 in “International Journal of Research in Dermatology” Minoxidil with PRP is the best treatment for hair loss.
1 citations,
November 2023 in “BMC chemistry” Tadalafil and Finasteride may help treat aggressive melanoma.
January 2023 in “International Journal of Trichology” Using both minoxidil and finasteride together is more effective for male hair loss than using either one alone.
September 2021 in “Clinical research in dermatology” 5-Alpha-Reductase inhibitors might help slow down hair loss in Frontal Fibrosing Alopecia but are not a primary treatment and need more research.
63 citations,
July 2018 in “The journal of investigative dermatology/Journal of investigative dermatology” JAK inhibitors can effectively reverse hair loss in people with alopecia areata.